GenPharm Cross License definition

GenPharm Cross License means that certain Cross License entered into by and between ABX, CGI, JTI, XT, and GenPharm International, Inc. effective as of March 26, 1997, as the same may be amended from time to time.
Sample 1Sample 2Sample 3
GenPharm Cross License means that certain Cross License Agreement, effective as of March 26, 1997, entered into by and among the parties, GenPharm International, Inc. ("GenPharm") and the other parties named therein, as the same may be amended from time to time.
Sample 1Sample 2Sample 3
GenPharm Cross License. IND," "Independent Discovery," "JTI," "Licensed Technology," "MTA," "Product," "Product Antigen," "[*]," "Product License," "Sublicense," "Sublicensee," "Territory," "XenoMouse," "XenoMouse Animals," and "Xenotech Agreement" shall have the meaning ascribed thereto in the [*] Product License.
Sample 1Sample 2Sample 3

Examples of GenPharm Cross License in a sentence

  • The rights and licenses granted to Licensee hereunder shall be subject to the GenPharm Cross License, and to the extent that this Agreement purports to grant greater rights to Licensee than is permitted under the GenPharm Cross License, such rights shall be granted only to the extent permitted under the GenPharm Cross License, and the terms of the GenPharm Cross License shall control.

  • Additionally, and without limiting the foregoing, the rights granted to CuraGen hereunder, including without limitation any grant of “exclusive” rights, shall be subject to the rights granted to or retained by GenPharm under the GenPharm Cross License Agreement.

  • If, at the time of the request, CGI is an Affiliate of ABX (as the term Affiliate is defined in the GenPharm Cross License), then CGI shall terminate certain of its rights under the Direct Sublicense of GenPharm Rights entered into by and between CGI and XT effective as of November __, 1997 by completing and delivering to XT the attached form Notice of Partial Termination of Direct Sublicense attached hereto as Attachment C.

  • During such time as CGI is an Affiliate of ABX (as the term "Affiliate" is defined in the GenPharm Cross License), CGI shall have a direct sublicense from XT under the GenPharm Cross License for Covered Products related to that CGI Antigen, as set forth in the Direct Sublicense of GenPharm Rights entered into by and between XT and CGI effective as of October ___, 1997 (the "Direct Sublicense of GenPharm Rights").

  • All rights and licenses granted hereunder shall be subject to the GenPharm Cross-License, and to the extent that this Agreement (or any license or CGI Product Sublicense granted or permitted under this Agreement) purports to grant greater rights to any Grantee or third party than is permitted under the GenPharm Cross License, such rights shall be granted only to the extent permitted under the GenPharm Cross License, and the terms of the GenPharm Cross License shall control.

  • It is understood and agreed that (x) as to ABX-Controlled Rights, the grant of rights under this Section 2.5 shall be subject to and limited in all respects by the terms of the applicable ABX In-License(s) pursuant to which such ABX-Controlled Rights were granted to ABX and (y) the rights and sublicenses granted to CGI under this Section 2.5 or any other provision of this Agreement shall be subject in all respects to the GenPharm Cross License.

  • ABX shall arrange for Product Licenses entered into by ABX for CGI Antigens during such time as CGI is an Affiliate of ABX (as the term "Affiliate is defined in the GenPharm Cross License) to contain provisions specifying that rights under the GenPharm Cross License conveyed to ABX under such Product Licenses are subordinate to the rights conveyed to CGI under the Direct Sublicense of GenPharm Rights.

  • With regard to rights and sublicenses under the GenPharm Cross License sublicensed to ABX under Section 3.1 above ("ABX's [***] Certain information on this page has been omitted and filed separately with the Commission.

  • Additionally, and without limiting the foregoing, the Parties acknowledge and agree that pursuant to the GenPharm Cross License Agreement, the rights granted to AZ hereunder under certain XenoMouse Patent Rights, including any grant of “exclusive” rights, shall be subject to the rights granted to or retained by GenPharm International, Inc.

  • Additionally, and without limiting the foregoing, the rights granted to CuraGen hereunder, including without limitation any grant of "exclusive" rights, shall be subject to the rights granted to or retained by GenPharm under the GenPharm Cross License Agreement.

Related to GenPharm Cross License

  • Cross License Agreement means that certain Cross License Agreement between and among Medarex, Cell Genesys, Inc., Abgenix, Inc., Xenotech, L.P. and Japan Tobacco Inc., dated March 26, 1997.

  • End User License Agreement means a license grant or end user license agreement governing software as further described in this Agreement or any applicable Appendix.

  • Technology License Agreement means the agreement in the form of Exhibit H hereto.

  • Sublicense Agreement means any agreement or arrangement pursuant to which Licensee (or an Affiliate or Sublicensee) grants to any third party any of the license rights granted to the Licensee under the Agreement.

  • Company License Agreements means any license agreements granting any right to use or practice any rights under any Intellectual Property (except for such agreements for off-the-shelf products that are generally available for less than $25,000), and any written settlements relating to any Intellectual Property, to which the Company is a party or otherwise bound; and the term “Software” means any and all computer programs, including any and all software implementations of algorithms, models and methodologies, whether in source code or object code.

  • Sub-Licensee means all person/ agency with whom Licensee has executed sub license agreement as per terms and conditions of license agreement executed between DMRC and the Licensee, for commercial utilization of the Bare Spaces.

  • IP License Agreement shall have the meaning set forth in Section 1.2.

  • License Agreement means the agreement between SAP (or an SAP SE Affiliate, or an authorized reseller) under which Customer procured the rights to use SAP Software or a Cloud Service.

  • Patent License Agreement means the Patent License Agreement substantially in the form of Exhibit C.

  • Intellectual Property License Agreement means the intellectual property license agreement substantially in the form attached as Exhibit B to the Contribution and Distribution Agreement.

  • Software License Agreement means the Motorola Software License Agreement (Exhibit A).

  • Retail license means one of the following licenses issued under this title:

  • Business License means a license issued by the Department to a medical marijuana dispensary, grower, processor, testing laboratory, or transporter.

  • Third Party License means licenses from third parties governing third party software embedded or used in the Trading Platform.

  • License Agreements shall have the meaning set forth in Section 8.11 hereof.

  • Trademark License Agreement means that certain Trademark License Agreement in substantially the form attached hereto as Exhibit F.

  • Intercompany License Agreement means any cost sharing agreement, commission or royalty agreement, license or sublicense agreement, distribution agreement, services agreement, intellectual property rights transfer agreement, any related agreements or similar agreements, in each case where all parties to such agreement are one or more of the Company or a Restricted Subsidiary.

  • License Key means a unique key-code that enables Licensee to run Software subject to the obtained User Pack.

  • Software licensing agreement means any agreement, regardless of how designated, that defines the intellectual property rights for, or the rights to use, any software product. A software licensing agreement must address only terms directly associated with licensing the right to use the software and must not address any of the work governed by the contract or any services (other than warranty services regarding the software code or associated documentation).

  • End User License means any license terms imposed by any Third Party Vendor on Customers and End Users. “Force Majeure Event” means an event or occurrence:

  • Licensing Agreement means a commercial agreement between a design approval holder and a production approval holder (or applicant) formalizing the rights and duties of both parties to use the design data for the purpose of manufacturing the product or article.

  • Third Party Licensor means the relevant licensor of any Third Party Data or any Third Party Trade Xxxx;

  • Company Licensed IP means all Intellectual Property rights owned or purported to be owned by a third party and licensed to the Company or any Company Subsidiary or to which the Company or any Company Subsidiary otherwise has a right to use.

  • Biologics License Application or “BLA” means an application requesting permission from the FDA to introduce, or deliver for introduction, a biological product into interstate commerce, or any similar application or submission for marketing authorization of a product filed with a Regulatory Authority to obtain Regulatory Approval for such product in a country or group of countries.

  • Third Party Licenses has the meaning set forth in Section 3.

  • CREFC® Intellectual Property Royalty License Fee With respect to each Mortgage Loan (including any REO Mortgage Loan) and for any Distribution Date, the amount accrued during the related Interest Accrual Period at the CREFC® Intellectual Property Royalty License Fee Rate on, in the case of the initial Distribution Date, the Cut-Off Date Balance of such Mortgage Loan and, in the case of any subsequent Distribution Date, the Stated Principal Balance of such Mortgage Loan as of the close of business on the Distribution Date in the related Interest Accrual Period; provided that such amounts shall be computed for the same period and on the same interest accrual basis respecting which any related interest payment due or deemed due on the related Mortgage Loan is computed and shall be prorated for partial periods. For the avoidance of doubt, the CREFC® Intellectual Property Royalty License Fee shall be payable from the Lower-Tier REMIC.